Bayer CropScience Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 4 Aug 2026 | Fertilizers & Agrochemicals | Market Cap: ₹19.3K Cr
Aspirational revenue growth target is high single-digit to low double-digit over the next 3-5 years. Revenue growth guidance is high single-digit to low double-digit for the next 3-5 years, driven by strategic portfolio focus and doubling corn seeds portfolio.
From Bayer CropScience Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹4,072
Market Cap
₹19.3K Cr
P/E Ratio
26.4
Revenue Rank
Margin Rank
How does Bayer CropScience Ltd rank in Fertilizers & Agrochemicals?
Compare Bayer CropScience Ltd against every Fertilizers & Agrochemicals company this quarter on revenue, margins and earnings-call signals.
Bayer CropScience Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.1K Cr, net profit ₹162 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 4- →Aspirational revenue growth target is high single-digit to low double-digit over the next 3-5 years.
- →Growth driven by a strong, strategic focus on Crop Protection (CP) portfolio backed by innovations and doubling of corn seeds portfolio.
- →Expect steady improvement in profitability alongside revenue growth, aiming for around 100 basis points margin improvement over 2-3 years starting from FY 2024-25.
- →Volume growth is important, but margins have limitations, especially in corn due to higher incremental production costs influenced by weather.
- →Pricing power and competitive positioning through new product launches (e.g., BICOTA, Camalus, Xivana Smart) will support growth.
- →Sustainable growth requires balancing cost efficiencies, top-line growth, and operational expense control.
- →Overall guidance assumes normalized operating conditions without major one-time items.
📈 Profitability & Margins
Rank 2- →Revenue growth guidance is high single-digit to low double-digit for the next 3-5 years, driven by strategic portfolio focus and doubling corn seeds portfolio.
- →Profitability expected to improve steadily alongside revenue growth, targeting a 100 basis points (bps) improvement in margin starting from the base year FY24-25 over the next 2-3 years.
- →Margin improvement depends on multiple factors including supply chain changes and pricing; margins are not expected to reach very high levels (e.g., 50% EBIT margin is unrealistic).
- →EPS had declined due to high input costs and supply chain challenges but is expected to stabilize as these issues ease.
- →Growth in revenue and margin improvement are aspirational and assume normal business conditions without one-time costs.
- →Sustained profitability improvement from FY24-25 is the company's aspiration amidst uncertain market conditions.
🏗️ Capital Expenditure Plans
Yes- →Bayer CropScience is focusing on expanding its corn seeds portfolio, aiming for a continued doubling as part of its 3-5 year strategic framework.
- →Significant new product launches are planned, including major proprietary launch "Plenexos" (insecticide) and other compounds like Xivana Smart targeting fruit and vegetable segments.
- →The company is enhancing backward integration for larger compound manufacturing within India to reduce reliance on imports from high currency countries and improve supply chain resilience.
- →Go-to-market transformation includes shifting focus toward partnerships and digital channels in less profitable areas to improve operational efficiency and margin per head.
- →Investment emphasis is on innovation-driven product supply, increased local sourcing in India and Asia, and supporting sustainability and quality standards.
- →Overall, the strategy involves high single-digit to low double-digit revenue growth supported by capex targeted at innovation, production capacity, and go-to-market recalibration.
💰 Fundraising & Capital Structure
No information📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Bayer CropScience Ltd Q2 FY26 results?
Aspirational revenue growth target is high single-digit to low double-digit over the next 3-5 years. Revenue growth guidance is high single-digit to low double-digit for the next 3-5 years, driven by strategic portfolio focus and doubling corn seeds portfolio.
What is Bayer CropScience Ltd share price analysis?
Bayer CropScience Ltd currently shows a neutral. The stock trades at a P/E of 26.4 with a market cap of ₹19,338 Cr. Investors should review the full earnings analysis for detailed insights.
Is Bayer CropScience Ltd planning capital expenditure?
Bayer CropScience is focusing on expanding its corn seeds portfolio, aiming for a continued doubling as part of its 3-5 year strategic framework.
Keep Bayer CropScience Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.